American Healthcare REIT CEO takes medical leave

American Healthcare REIT, Inc. announced that Chief Executive Officer, President and director Danny Prosky is taking a leave of absence effective February 3, 2026 due to a recent medical event.

Rhea-AI Filing Summary

American Healthcare REIT, Inc. announced that Chief Executive Officer, President and director Danny Prosky is taking a leave of absence effective February 3, 2026 due to a recent medical event. The board appointed Jeffrey T. Hanson, Chairman of the Board and former Chief Executive Officer from 2015 to 2021, as Interim Chief Executive Officer and President, also effective February 3, 2026. The company issued a press release on February 4, 2026 describing these leadership changes, which is included as an exhibit to this report.

Positive

• None.

Negative

• CEO leave of absence due to medical event: The sudden leave of absence of CEO, President and director Danny Prosky effective February 3, 2026 introduces leadership uncertainty at the top of American Healthcare REIT, Inc., which can be material for strategic oversight and execution.

Insights

Corporate governance and REIT analyst

CEO medical leave introduces leadership uncertainty, partly offset by an experienced interim successor.

American Healthcare REIT disclosed that CEO, President and director Danny Prosky is on leave of absence effective February 3, 2026 due to a recent medical event. Sudden leadership changes at the top level can affect strategic continuity and stakeholder confidence.

The board appointed Chairman Jeffrey T. Hanson, who previously served as CEO from 2015 to 2021, as Interim CEO and President. His prior tenure and current board role suggest familiarity with the portfolio and operations, which may help maintain continuity during the transition.

The company issued a press release on February 4, 2026 describing these changes. Future company communications and filings may provide additional detail on the duration of the interim arrangement and any further board or management adjustments related to this leadership change.

8-K Event Classification

2 items: 5.02, 7.01

2 items

Item 5.02 Departure of Directors or Certain Officers; Election of Directors; Appointment of Certain Officers Governance

Key personnel changes including departures, elections, or appointments of directors and executive officers.

Item 7.01 Regulation FD Disclosure Disclosure

Material non-public information disclosed under Regulation Fair Disclosure, often investor presentations or guidance.

FAQ

AI-generated questions and answers. How Rhea-AI works. Not financial advice.

What leadership change did American Healthcare REIT (AHR) disclose in this 8-K?

American Healthcare REIT announced that CEO, President and director Danny Prosky is taking a leave of absence effective February 3, 2026, due to a recent medical event. The board appointed Chairman Jeffrey T. Hanson as Interim Chief Executive Officer and President, also effective February 3, 2026.

Who is Jeffrey T. Hanson, the Interim CEO of American Healthcare REIT (AHR)?

Jeffrey T. Hanson is Chairman of the Board of American Healthcare REIT and has been appointed Interim Chief Executive Officer and President effective February 3, 2026. He previously served as the company’s Chief Executive Officer from 2015 to 2021, providing prior leadership experience with this REIT.

Why is American Healthcare REIT CEO Danny Prosky taking a leave of absence?

Danny Prosky, CEO, President and director of American Healthcare REIT, is taking a leave of absence effective February 3, 2026, due to a recent medical event. The filing does not provide further detail, but it confirms the board’s decision to appoint an experienced interim successor.

When did American Healthcare REIT (AHR) communicate these management changes publicly?

American Healthcare REIT issued a press release on February 4, 2026, describing CEO Danny Prosky’s leave of absence and the appointment of Jeffrey T. Hanson as Interim CEO and President. That press release is attached to the report as Exhibit 99.1 and incorporated by reference.

Does the 8-K describe any changes to the American Healthcare REIT board structure?

The 8-K states that Jeffrey T. Hanson remains Chairman of the Board and is now also Interim Chief Executive Officer and President. It does not describe additional changes to the composition of the board or other director departures beyond this leadership role adjustment.

Where can investors find more background on Interim CEO Jeffrey T. Hanson of AHR?

The filing notes that biographical information for Interim CEO and President Jeffrey T. Hanson is available in American Healthcare REIT’s definitive proxy statement for its 2025 Annual Meeting of Stockholders, which was filed with the U.S. Securities and Exchange Commission on April 10, 2025.

AI-generated analysis. How Rhea-AI works. Not financial advice.

Understanding 8-K Material Events →

See more from StockTitan in Google Search and AI answers. Adds StockTitan as a preferred source · opens Google

Add on Google Not now

Accepted by SEC EDGAR 02/04/2026 - 04:32 PM Learn about SEC filing dates

0001632970false00016329702026-02-032026-02-03

UNITED STATES
SECURITIES AND EXCHANGE COMMISSION
WASHINGTON, D.C. 20549

FORM 8-K

CURRENT REPORT

Pursuant to Section 13 or 15(d) of the Securities Exchange Act of 1934

Date of Report (Date of earliest event reported): February 03, 2026

American Healthcare REIT, Inc.

(Exact name of Registrant as Specified in Its Charter)

Maryland			001-41951	47-2887436
(State or Other Jurisdiction of Incorporation)			(Commission File Number)	(IRS Employer Identification No.)
18191 Von Karman Avenue, Suite 300
Irvine, California				92612
(Address of Principal Executive Offices)				(Zip Code)

Registrant’s Telephone Number, Including Area Code: 949 270-9200

Not Applicable

(Former Name or Former Address, if Changed Since Last Report)

Check the appropriate box below if the Form 8-K filing is intended to simultaneously satisfy the filing obligation of the registrant under any of the following provisions:

☐Written communications pursuant to Rule 425 under the Securities Act (17 CFR 230.425)

☐Soliciting material pursuant to Rule 14a-12 under the Exchange Act (17 CFR 240.14a-12)

☐Pre-commencement communications pursuant to Rule 14d-2(b) under the Exchange Act (17 CFR 240.14d-2(b))

☐Pre-commencement communications pursuant to Rule 13e-4(c) under the Exchange Act (17 CFR 240.13e-4(c))

Securities registered pursuant to Section 12(b) of the Act:

Title of each class		Trading Symbol(s)		Name of each exchange on which registered
Common Stock, $0.01 par value per share		AHR		New York Stock Exchange

Indicate by check mark whether the registrant is an emerging growth company as defined in Rule 405 of the Securities Act of 1933 (§ 230.405 of this chapter) or Rule 12b-2 of the Securities Exchange Act of 1934 (§ 240.12b-2 of this chapter).

Emerging growth company ☐

If an emerging growth company, indicate by check mark if the registrant has elected not to use the extended transition period for complying with any new or revised financial accounting standards provided pursuant to Section 13(a) of the Exchange Act. ☐

Item 5.02 Departure of Directors or Certain Officers; Election of Directors; Appointment of Certain Officer; Compensatory Arrangements of Certain Officers.

We announced today that Danny Prosky, our Chief Executive Officer, President and director, is taking a leave of absence, effective February 3, 2026, due to a recent medical event. Our board of directors has appointed Jeffrey T. Hanson, our Chairman of the Board and our former Chief Executive Officer from 2015 to 2021, to serve as our Interim Chief Executive Officer and President, effective as of February 3, 2026. Biographical information for Mr. Hanson may be found in our definitive proxy statement relating to our 2025 Annual Meeting of Stockholders filed with the U.S. Securities and Exchange Commission on April 10, 2025.

Item 7.01 Regulation FD Disclosure.

On February 4, 2026, we issued a press release relating to the matters described in Item 5.02 above. A copy of the press release is attached hereto as Exhibit 99.1 to this Current Report on Form 8-K and is incorporated by reference herein.

The information contained in this Item 7.01, including Exhibit 99.1, is being “furnished” and shall not be deemed “filed” for the purposes of Section 18 of the Securities Exchange Act of 1934, as amended, or otherwise subject to the liabilities of that section, nor shall such information be deemed incorporated by reference in any filing under the Securities Act of 1933, as amended.

Item 9.01 Financial Statements and Exhibits.

(d) Exhibits.

Exhibit No.		Description
99.1		American Healthcare REIT, Inc. Press Release, dated February 4, 2026
104		Cover Page Interactive Data File (embedded within the Inline XBRL document)

SIGNATURES

Pursuant to the requirements of the Securities Exchange Act of 1934, the registrant has duly caused this report to be signed on its behalf by the undersigned hereunto duly authorized.

			American Healthcare REIT, Inc.
Date:	February 4, 2026	By:	/s/ Jeffrey T. Hanson
			Jeffrey T. Hanson, Interim Chief Executive Officer and President